IPO Issue Details
Issue Price / Price Band₹36 per share (Fixed Price)
Face Value₹10 Per Share
Lot Size3,000 Shares per Lot
Total Issue Size9,00,000 shares (aggregating up to ₹3.24 Cr)
Issue TypeFixed Price IPO
Sale Type / CategoryFresh Capital
Exchange / PlatformBSE SME
IPO TypeSME
Subscription OpenFri, 31 Dec 2021
Subscription CloseWed, 05 Jan 2022
Anchor AllotmentThu, 30 Dec 2021
Basis of AllotmentMon, 10 Jan 2022
Initiation of RefundsTue, 11 Jan 2022
Credit of Shares to DematWed, 12 Jan 2022
Listing DateThu, 13 Jan 2022
UPI Mandate Deadline2022-01-05
Application & Investment Details
Retail — Min (1 Lots)₹1,08,000 — 3,000 shares
Retail — Max (13 Lots)₹1,404,000 (13 Lots)
HNI — Min (2 Lots)₹2,16,000 — 6,000 shares
P/E Ratio (Pre-IPO)133x
Net Offer to Public8,52,000 shares (aggregating up to ₹3.07 Cr)
Reserved for Market Maker48,000 shares (aggregating up to ₹0.1728 Cr)
Pre-IPO Promoter Holding12,00,000 shares
Post-IPO Promoter Holding21,00,000 shares
About Fabino Life Sciences Ltd.
Fabino Life Sciences is engaged in the manufacturing, marketing, trading, and packing of pharmaceutical and other wellness-focused consumer products. The company's core business is the marketing of pharmaceutical formulation & products in the domestic market through their own distribution network and sales force under their brand name, getting ayurvedic formulations manufactured through loan licensing facilities, packing, labeling, etc. The company export wellness and FMCG products like coffee, malt powder, protein powder, hair shampoo marketed by them.Currently, the company has over 70 launched and active products available in markets categorized into (i) Allopathic, (ii) Covid 19, (iii) Food & Wellness, (iv) Herbal, (v) Veterinary, (vi) Multi-Vitamin, segments. The shampoo and hair maintenance products from the company are under the brand - Keepshine, while all the others products are marketed under the brand - Fabino. The company has its manufacturing unit in the National Capital Region, India.Competitive Strengths:An experienced promoter from the pharmaceutical industryDiverse product portfolioMore than 70 registrations for trademarks of productsLow debt balance sheetStrong marketing and distribution network
Objects of the Issue
Fabino Life Sciences Ltd. proposes to utilise the net proceeds from the Issue for the following objects:
1
1 Part Repayment of Loans
0.25
2
2 Funding Working capital requirements
2.05
3
3 General Corporate Purpose
0.50
Shareholding & Lock-in
Pre-IPO Promoter Holding
12,00,000 shares
Post-IPO Promoter Holding
21,00,000 shares